documents: FDA-2008-P-0411-0018

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2008-P-0411-0018 FDA FDA-2008-P-0411 Exhibit 1 - "Caraco Letter to FDA/CDER , re: ANDA 77-571/Repaglinide, May 29, 2009" - [Caraco Pharmaceuticals Laboratories, LTD - (Winston & Strawn LLP) - Reply Comment] re FDA-2008-P-0411-0017 Supporting & Related Material RC-Reply Comment (Supporting and Related Material) 2009-06-17T04:00:00Z 2009 6     2009-06-18T00:15:06Z   0 0 09000064809d05f7

Links from other tables